Sale!

Cardiovascular Safety in Drug Development and Therapeutic Use New Methodologies and Evolving Regulatory Landscapes 1st Edition J. Rick Turner

Name: Cardiovascular Safety in Drug Development and Therapeutic Use New Methodologies and Evolving Regulatory Landscapes 1st Edition J. Rick Turner
SKU: EB-5736184
Availability: InStock

Original price was: $50.00.Current price is: $25.00.

Cardiovascular Safety in Drug Development and Therapeutic Use New Methodologies and Evolving Regulatory Landscapes 1st Edition J. Rick Turner Digital Instant Download

Author(s): J. Rick Turner, Dilip R. Karnad, Snehal Kothari (auth.)

ISBN(s): 9783319403458, 9783319403472, 3319403451, 3319403478

Edition: 1

File Details: PDF, 3.35 MB

Year: 2017

Language: English

SKU: EB-5736184 Category: Medicine Tags: 3319403478, 9783319403472, Cardiovascular, Dilip R. Karnad, J. Rick Turner, Snehal Kothari (auth.)

Description

This completed downloadable of Cardiovascular Safety in Drug Development and Therapeutic Use New Methodologies and Evolving Regulatory Landscapes 1st Edition J. Rick Turner .

Instant downloaded Cardiovascular Safety in Drug Development and Therapeutic Use New Methodologies and Evolving Regulatory Landscapes 1st Edition J. Rick Turner pdf docx epub after payment.

Product details:

ISBN-10 : 3319403478
ISBN-13 : 9783319403472
Author : J. Rick Turner; Dilip R. Karnad; Snehal Kothari

At a time when the field of cardiac safety is going through important changes, this unique book provides the rationale for, and cutting-edge explanations of, new regulatory landscapes that will likely govern cardiac safety assessments globally for the foreseeable future. Exposure-response modeling is already being accepted by regulatory agencies in lieu of the traditional Thorough QT/QTc Study, and the Comprehensive in vitro Proarrhythmia Assay initiative is well under way. Developments in the field of cardiovascular safety are also described and discussed in the book.

Table of contents:

Part I: Introduction

Part II: A Primer of Biological and Physiological Considerations

Part III: A Primer of Statistical Considerations

Part IV: Proarrhythmic Cardiac Safety

Part VI: Additional Considerations in General Drug Safety and Therapeutic Use

People also search:

are cardiovascular technologist in demand

what is drug safety and pharmacovigilance

do statin drugs prevent heart disease

does cardiovascular disease include stroke

are statins cardiovascular drugs